Name: Bladder Cancer Panel Discussion: Management of Non-Muscle Invasive Bladder Cancer, Trimodality Therapy, 1st Line Systemic Therapy for Metastatic Urothelial Carcinoma
Uploaded: 2019-11-22T10:36:59.951812+00:00
Duration: 15 min 41 s

Fox Chase Cancer Center

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

10 seconds

Playback speed

Bladder Cancer Panel Discussion: Management of Non-Muscle Invasive Bladder Cancer, Trimodality Therapy, 1st Line Systemic Therapy for Metastatic Urothelial Carcinoma

By Fox Chase Updates in Bladder and Kidney Cancer 2019 FEATURING Robert G. Uzzo

139 views

November 22, 2019

Robert G. Uzzo, MD, MBA, FACS, Fox Chase Cancer Center, Philadelphia, PA

Dr. Uzzo is ...
read more ↘

Comments 0

Login

Login

Join VuMedi

Fox Chase Cancer Center

Bladder Cancer Panel Discussion: Management of Non-Muscle Invasive Bladder Cancer, Trimodality Therapy, 1st Line Systemic Therapy for Metastatic Urothelial Carcinoma

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

2019 Updates in the Management of Non-Muscle Invasive Bladder Cancer…

Muscle-Invasive Bladder Cancer: Who Are the Ideal Candidates for Bla…

2019 1st Line Systemic Therapy for Metastatic Urothelial Carcinoma: …

Bladder Cancer Panel Discussion: Management of Non-Muscle Invasive B…